Intraoperative transfection of vein grafts with the NFκB decoy in a canine aortocoronary bypass model: A strategy to attenuate intimal hyperplasia

Annals of Thoracic Surgery

Volumn 74, Issue 4, 2002, Pages 1132-1137

  Shintani, Takuji ^a   Sawa, Yoshiki ^a   Takahashi, Toshiki ^a   Matsumiya, Goro ^a   Matsuura, Nariaki ^b   Miyamoto, Yuji ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY MUSCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; DOG; GENETIC TRANSFECTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT;

ANIMALS; CORONARY ARTERY BYPASS; DOGS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; SAPHENOUS VEIN; TRANSFECTION; TUNICA INTIMA; TUNICA MEDIA;

EID: 0036797999     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)03921-8     Document Type: Conference Paper

References (25)

1. Hamby RI, Aintablian A, Handler M, et al. Aortocoronary saphenous vein bypass grafts: long-term patency, morphology and blood flow in patients with patent grafts early after surgery. Circulation 1979;60:901-9.
2. Acinapura AJ, Rose DM, Cunningham JN, Jacobowitz IJ, Kramer MD, Zisbrod Z. Internal mammary artery bypass: effect on longevity and recurrent angina pectoris in 2900 patients. Eur J Cardiothorac Surg 1989;3:321-5.
3. Loop FD, Lytle BW, Cosgrove DM. Influence of the internal mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314:1-6.
4. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery, and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 1985;89:248-58.
5. Cox JL, Chiasson DA, Gotlieb AI. Stranger in a strange land: the pathogenesis of saphenous vein grafts stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 1991;34:45-68.
6. Angelini GD, Bryan AJ, Williams HMJ, et al. Time-course of medial, and intimal thickening in pig venous arterial grafts: relationship to endothelial injury and cholesterol accumulation. J Thorac Cardiovasc Surg 1992;103:1093-103.
7. Bryan AJ, Angelini GD. The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr Opin Cardiol 1994;9:641-9.
8. Angelini GD, Bryan AJ, Williams HMJ, Morgan R, Newby AC. Distension promotes platelet and leukocyte adhesion and reduces short term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg 1990;99:433-9.
9. Angelini GD, Bryan AJ, Hunter S, Newby AC. A surgical technique that preserves human saphenous vein functional integrity. Ann Thorac Surg 1992;53:871-4.
10. O'Neil GS, Chester AH, Schyns CJ, Tadjkarimi S, Borland JAA, Yacoub MH. Effect of surgical preparation and arterialization on vasomotion of human saphenous vein. J Thorac Cardiovasc Surg 1994;107:699-706.
11. Schwartz LB, O'Donohue MK, Purut CM, Mikat EM, Hagen PO, McCann RL. Myointimal thickening in experimental vein grafts is dependent on wall tension. J Vasc Surg 1992;15:176-186.
12. Soyombo AA, Angelini GD, Bryan AJ, Newby AC. Surgical preparation induces injury and promotes smooth muscle proliferation in a culture of human saphenous vein. Cardiovasc Res 1993;27:1961-7.
13. Mann MJ, Gibbons GH, Hutchinson H, et al. Pressure-mediated oligonucleotide transfection of rat, and human cardiovascular tissues. Proc Natl Acad Sci USA 1999;96:6411-6.
14. Mann MJ, Whittemore AD, Donaldson MC, et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomized, controlled trial. Lancet 1999;354:1493-8.
15. Gottlob R. The preservation of venous endothelium by dissection without touching and by an atraumatic technique of vascular anastomosis. Minerva Chir 1977;32:693-700.
16. Angelini GD, Passani SL, Breckenridge IM, Newby AC. Nature and pressure dependence of damage induced by distension of human saphenous vein coronary artery bypass grafts. Cardiovasc Res 1987;21:902-7.
17. Bai H, Masuda J, Sawa Y, et al. Neointima formation after vascular stent implantation. Spatial and chronological distribution of smooth muscle cell proliferation and phenotypic modulation. Arterioscler Thromb 1994;14:1846-53.
18. Luscher TF, Espinosa E, Dubey RK, Yang Z. Vascular biology if human artery and bypass graft disease. Curr Opin Cardiol 1993;8:963-74.
19. Von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995;92:1137-41.
20. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-32.
21. Olson NE, Chao S, Lindner V, Reidy MA. Intimal smooth muscle cell proliferation after balloon injury: the role of basic fibroblast growth factor. Am J Pathol 1992;140:1017-23.
22. Shin WS, Szuba A, Rockson SG. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 2002;160:91-102.
23. Ueda A, Okuda K, Ohno S, et al. NF-κB, and Sp-1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994;153:2052-63.
24. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T. Functional analysis of the human vascular cell, adhesion molecule 1 promoter. J Exp Med 1992;176:1583-93.
25. Kikuchi S, Umemura K, Kondo K, Saniabadi AR, Nakashima M. Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening. Arterioscler Thromb Vasc Biol 1998;18:1069-78.